Mechanisms of complement resistance induced by non-lethal complement attack and by growth arrest

Immunology

Volumn 90, Issue 4, 1997, Pages 647-653

  Marchbank, K J ^a   Van Den Berg, C W ^a   Morgan, B P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; DECAY ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ARTICLE; CELL CYCLE; CELL GROWTH; CELL STRAIN K 562; COMPLEMENT ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0030893364     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00197.x     Document Type: Article

References (34)

1. MULLER-EBERHARD H.J. (1988) Molecular organisation and function of the complement system. Annu Rev Biochem 57, 321.
2. MAYER M.M. (1961) Development of a one hit theory of immune haemolysis. In: Immunochemical Approaches to Problems in Microbiology, (eds M. Heidlberger & D.J. Plescia) p. 268. Rutgers, New Jersey.
3. KOSKI C.L., RAMM L.R., HAMMER C.H., MAYER M.M. & SHIN M.L. (1983) Cytolysis of nucleated cell by complement: cell death display multi-hit characteristics. Proc Natl Acad Sci USA 80, 3816.
4. MORGAN B.P., DANKERT J.R. & ESSER A.F. (1987) Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis. J Immunol 138, 246.
5. OHANIAN S.H. & SCHLAGER S.I. (1981) Humoral immune killing of nucleated cells; mechanisms of complement mediated attack and target cell defense. CRC Crit Rev Immunol 1, 165.
6. SHIN M.L. & CARNEY D.F. (1988) Cytotoxic action and other metabolic consequences of terminal complement proteins. Prog Allergy 40, 44.
7. MORGAN B.P. (1989) Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem J 264, 1.
8. BOYLE M.D.P., OHANIAN S.H. & BORSOS T. (1976) Studies on the terminal stages of antibody-complement mediated killing of a tumour cell. J Immunol 116, 1276.
9. FISHELSON Z., KOPE E. & REITER Y. (1988) Phosphorylation, phosphatidyinositol turnover and resistance to C damage. FASEB J 2, A872.
10. FISHELSON Z., KKOPF E., PAAS Y., ROSS L. & REITER Y. (1989) Protein phosphorylation as a mechanism of resistance against complement damage. Prog Immunol 7, 205.
11. CARNEY D.F., LANG T.J. & SHIN M.L. (1990) Terminal complement complexes generate multiple signal messengers: protein kinase C but not cAMP is involved in rapid elimination of TCC from the surface of Ehrlich cells. J Immunol 145, 623.
12. OHANIAN S.H., YAMAZAKI M., SCHLAGER S.I. & FAIBISCH M. (1983) Cell growth-dependent variation in the sensitivity of human and mouse tumour cells to complement-mediated lysis. Cancer Res 43, 491.
13. RIETER Y., CIOBOTARIN A. & FISHELSON Z. (1992) Sublytic complement attack protects tumour cells from lytic doses of antibody and complement. Eur J Immunol 22, 1207.
14. REITER Y. & FISHELSON Z. (1992) Complement membrane attack complexes induce in human leukemic cells rapid expression of large proteins (L-CIP). Mol Immunol 29, 771.
15. MARCHBANK K.J., MORGAN B.P. & VAN DEN BERG C.W. (1995) Regulation of CD59 expression on K562 cells; effects of phorbol myristate acetate, cross-linking antibody and non-lethal complement attack. Immunology 85, 146.
16. CARTER N.P. (1990) Measurement of cellular subsets using antibodies. In: Flow Cytometry: a Practical Approach, (ed. M.G. Ormerod.) p. 64. Oxford University Press, Oxford.
17. MORGAN B.P., VAN DEN BERG G.W., DAVIES E.V., HALLET M.B. & HOREJSI V. (1993) Cross-linking of CD59 and of other glycosyl phosphatidylinositol-linked molecules on neutrophils triggers cell activation via tyrosine kinase. Eur J Immunol 23, 2841.
18. STRYER L. (1988) Biosynthesis of nucleotides. In: Biochemistry, (3rd edn), chp. 25, p. 615. W.H. Freeman & Co., New York, USA.
19. LEE M.Y.M.T., TAN C.K., DOWNEY K.M. & SO A. (1981) Structural and functional properties of calf thymus DNA polymerase Delta. Prog Nucleic Acids Res Mol Biol 26, 83.
20. LALANDE M. (1990) A reversible arrest point in the late G1 phase of the mammalian cell cycle. Exp Cell Res 186, 332.
21. URBANI L., SHERWOOD S.W. & SCHIMKE R.T. (1995) Dissociation of nuclear and cytoplasmic cell cycle progression by drugs employed in cell synchronisation. Exp Cell Res 219, 159.
22. SHERWOOD S.W., KUNG A.L., ROITELMAN J., SIMONI R.D. & SCHIMKE R.T. (1993) In vivo inhibition of cyclin B degradation and induction of cell-cycle arrest in mammalian cells by the cysteine protease inhibitor N-actylleucylleucylnorleucinal. Proc Natl Acad Sci USA 90, 3353.
23. VINDELOV L.L., CHRISTENSEN I.J. & NISSEN N.I. (1983) A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3, 323.
24. KALAMBAKAS S.A., ROBERTSON F.M., O'CONNELL S.M., SINHA S., VISHNUPAD K. & KARP G.I. (1993) Adenosine diphosphate stimulation of cultured hematopoietic cell lines. Blood 81, 2652.
25. LEIBSON P.J., LOKEN M.R., SHAPIRO S.J. & SCHREIBER N. (1980) Direct determination of the influence of the cell cycle on the survival of tumour cells exposed to cytotoxic antibodies. Cancer Res 40, 56.
26. 2 cell-cycle stages of human lymphoid cells. J Nat Cancer Inst 53, 913.
27. SCHLAGER S.I., OHANIAN S.H. & BOROS T. (1977) Metabolic requirements for hormone induced resistance to antibody-complement mediated killing of tumour cells. J Immunol 119, 789.
28. GREEN H. & GOLDBERG B. (1960) The action of antibody and complement on mammalian cells. Ann N Y Acad Sci 87, 352.
29. MORGAN B.P. & MERI S. (1994) Membrane proteins that protect against complement lysis. Spring Sem Immunopathol 15, 369.
30. REITER Y., CIOBOTARIU A., JONES J., MORGAN B.P. & FISHELSON Z. (1995) Complement membrane attack complex, perforin and bacterial exotoxins induce in K562 cells Calcium-dependent cross-protection from lysis. J Immunol 155, 2203.
31. GUTTLER F. (1972) Phospholipid synthesis in HeLa cells exposed to immunoglobulin G and complement. Biochem J 128, 953.
32. PELLINGRINO M.A., FERRONE S., COOPER N.R., DIERICH M.P. & REISFELD R.A. (1974) Variation in susceptibility of a human lymphoid cell line to immune lysis during the cell cycle. Lack of correlation with antigen density and complement binding. J Exp Med 140, 578.
33. WARMSLEY A.M. & PASTERNAK C.A. (1970) The use of conventional and zonal centrifugation to study the life cycle of mammalian cells; phospholipid and macromolecular synthesis in neoplastic mast cells. Biochem J 119, 493.
34. BOSMANN H.B. & WINSTON R.A. (1970) Synthesis of glycoprotein, glycolipid, protein and lipid in synchronized L5178Y cells. J Cell Biol 45, 23.